Wednesday, July 17, 2019
Home Tags Biotechnology

Topic: Biotechnology

Latest Performance: Theravance Biopharma (NASDAQ: TBPH)

Theravance Biopharma is part of the biotechnology industry and is part of the healthcare sector. The company CEO is Rick E. Winningham. Theravance Biopharma Inc is a diversified biopharmaceutical company. It is engaged...
TSPSC AEE Hall Ticket

Present Trend: Syros Pharmaceuticals (NASDAQ: SYRS)

Syros Pharmaceuticals is in the healthcare sector and is in the biotechnology industry. The company CEO is Nancy A. Simonian. Syros Pharmaceuticals Inc is a biopharmaceutical company engaged in the understanding of the...

Recent Valuation: SELLAS Life Sciences Group (NASDAQ: SLS)

SELLAS Life Sciences Group is part of the biotechnology industry and trades as part of the healthcare sector. The company CEO is Angelos Stergiou. SELLAS Life Sciences Group Inc is a biopharmaceutical company....

Present Change: XBiotech (NASDAQ: XBIT)

XBiotech is in the biotechnology industry and trades as part of the healthcare sector. The company CEO is John Simard. XBiotech Inc is engaged in discovering and developing True Human antibody technology monoclonal...

Current Technicals: Xenon Pharmaceuticals (NASDAQ: XENE)

Xenon Pharmaceuticals is in the biotechnology industry and healthcare sector. The company CEO is Simon Pimstone. Xenon Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing a pipeline...
SSC Stenographer Admit Card 2017

Current Technicals: TESARO (NASDAQ: TSRO)

TESARO trades as part of the healthcare sector and is in the biotechnology industry. The company CEO is Leon O. Moulder. Tesaro Inc is an oncology-focused biopharmaceutical company. It focuses on developing treatments...

Stock to Watch: Trillium Therapeutics (NASDAQ: TRIL)

Trillium Therapeutics is in the healthcare sector and is part of the biotechnology industry. The company CEO is Niclas Stiernholm. Trillium Therapeutics Inc is an immuno-oncology company developing therapies for the treatment of...

Stock Under Review: Vital Therapies (NASDAQ: VTL)

Vital Therapies is part of the biotechnology industry and healthcare sector. The company CEO is Duane D. Nash. Vital Therapies Inc is a biotherapeutic company. The Company is engaged in developing a cell-based...

Current Valuation: Vanda Pharmaceuticals (NASDAQ: VNDA)

Vanda Pharmaceuticals is in the biotechnology industry and is part of the healthcare sector. The company CEO is Mihael Hristos Polymeropoulos. Vanda Pharmaceuticals Inc is a biopharmaceutical company focused on the development and...

Current Change: Xenetic Biosciences (NASDAQ: XBIO)

Xenetic Biosciences trades as part of the healthcare sector and trades as part of the biotechnology industry. The company CEO is Jeffrey F. Eisenberg. Xenetic Biosciences Inc is a clinical-stage biopharmaceutical company focused...

Latest News